SMEH Subsidiary Wins Ethamolin Exclusive Saudi Agency
Riyadh, Saudi Arabia — Scientific & Medical Equipment House Company (SMEH) announced that its wholly owned subsidiary, Qarqas Trading Company Pharmaceutical Warehouse, has secured the exclusive distribution agency for Ethamolin® in Saudi Arabia. The agreement runs until 2030 and covers a U.S. Food and Drug Administration-approved drug used to treat bleeding esophageal varices. The counterparty…
Saudi company Scientific & Medical Equipment House (SMEH) has signed an exclusive 2030 distribution agreement with Qarqas Trading Company Pharmaceutical Warehouse. This subsidiary will have sole rights to sell Ethamolin®, an FDA-approved drug for treating bleeding esophageal varices, throughout Saudi Arabia. The deal was officially registered by the Ministry of Commerce.
Ethamolin® is currently supplied to NUPCO, the government's central healthcare procurement body. Once the Saudi Food and Drug Authority (SFDA) grants the final license, Qarqas will hold full regulatory standing to market the drug independently, potentially expanding its availability beyond the government procurement channel.
Written by urgent.news from The Saudi Standard's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
